A Phase 3, Prospective, Randomized, Partially Blinded Multi-Center Study to Measure the Safety and Efficacy of NOVOCART 3D Compared ot Microfracture in the Treatment of Articular Cartilage Defects
Phase of Trial: Phase III
Latest Information Update: 06 Jun 2018
At a glance
- Drugs Autologous chondrocyte implantation (Primary)
- Indications Cartilage disorders
- Focus Therapeutic Use
- Sponsors Aesculap Biologics
- 01 Jun 2018 Planned End Date changed from 1 Aug 2021 to 1 Dec 2021.
- 01 Jun 2018 Planned primary completion date changed from 1 Jul 2018 to 1 Jul 2019.
- 20 Dec 2017 New trial record